The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries

International Journal of Cardiology

Volumn 119, Issue 3, 2007, Pages 319-325

  Svensson, Ann Marie ^a   Dellborg, Mikael ^a   Abrahamsson, Putte ^a   Karlsson, Thomas ^a   Herlitz, Johan ^a   Duval, Susan J ^b   Berger, Alan K ^b   Luepker, Russell V ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Prognosis; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SWEDEN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; URBAN HEALTH;

EID: 34250355666     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.156     Document Type: Article

References (21)

1. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999;100: 1132-3.
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
3. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
4. Lowel H., Koenig W., Engel S., Hormann A., and Keil U. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43 (2000) 218-226
5. Malmberg K., Yusuf S., Gerstein H.C., et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102 (2000) 1014-1049
6. McGuire D.K., Emanuelsson H., Granger C.B., et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J 21 (2000) 1750-1758
7. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 30 (1997) 171-179
8. Timmer J.R., Ottervanger J.P., Thomas K., et al. Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur Heart J 25 (2004) 926-931
9. Herlitz J., Malmberg K., Karlson B.W., Ryden L., and Hjalmarson A. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand 224 (1988) 31-38
10. McGovern P.G., Jacobs Jr. D.R., Shahar E., et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 104 (2001) 19-24
11. McGovern P.G., Herlitz J., Pankow J.S., et al. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Goteborg, Sweden. Am J Cardiol 80 (1997) 557-562
12. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
13. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
14. Goldberg R.J., Spencer F.A., Yarzebski J., et al. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol 94 (2004) 1373-1378
15. Rosamond W., Broda G., Kawalec E., et al. Comparison of medical care and survival of hospitalized patients with acute myocardial infarction in Poland and the United States. Am J Cardiol 83 (1999) 1180-1185
16. Herlitz J., McGovern P., Dellborg M., et al. Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Goteborg, Sweden. Am Heart J 146 (2003) 1023-1029
17. Malmberg K., and Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9 (1988) 259-264
18. Norhammar A., Malmberg K., Ryden L., Tornvall P., Stenestrand U., and Wallentin L. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24 (2003) 838-844
19. McGuire D.K., et al., for the NRMI Investigators. Women with diabetes Mellitus have the greatest reduction in myocardial infarction mortality over the past decade: Evaluation of 1,428,596 patients enrolled in the National Registry of Myocardial Infarction 2, 3, and 4 from 1994-2002. J Am Coll Cardiol 43 (2004) 284A
20. Kip K.E., et al., for the Investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients. Circulation 94 (1996) 1818-1825
21. Tschoepe D., Roesen P., Schwippert B., and Gries F.A. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 19 (1993) 122-128